2025
Declining postoperative ninety-day opioid prescriptions from 2010 to 2021 following hip arthroscopy for femoroacetabular impingement syndrome
Day W, Halperin S, Surucu S, Jimenez A, Katsnelson B, Zhu J, Grauer J. Declining postoperative ninety-day opioid prescriptions from 2010 to 2021 following hip arthroscopy for femoroacetabular impingement syndrome. Arthroscopy Sports Medicine And Rehabilitation 2025, 101078. DOI: 10.1016/j.asmr.2025.101078.Peer-Reviewed Original ResearchPostoperative opioid prescriptionsFemoroacetabular impingement syndromeOpioid prescriptionsPostoperative mmeElixhauser Comorbidity IndexHip arthroscopyNinety-dayHistory of chronic painImpingement syndromeAmount of narcoticsNational administrative databaseChronic painAdult patientsPatient sexPostoperative recoveryMultivariate linear regressionComorbidity indexMultivariate analysisComorbidity burdenClinical relevancePatientsExclusion criteriaSurgeryPatient variablesAdministrative databases
2024
Total Shoulder Arthroplasty in Patients With Hemophilia A: Greater Odds of Postoperative Bleeding and Thromboembolic Events but No Difference in 5-year Implant Survival
Gillinov S, Modrak M, Park N, Monahan P, Wilhelm C, Lee M, Mahatme R, Fong S, Moran J, Grauer J, Jimenez A. Total Shoulder Arthroplasty in Patients With Hemophilia A: Greater Odds of Postoperative Bleeding and Thromboembolic Events but No Difference in 5-year Implant Survival. Clinical Orthopaedics And Related Research® 2024, 483: 268-275. PMID: 39246053, PMCID: PMC11753735, DOI: 10.1097/corr.0000000000003209.Peer-Reviewed Original ResearchVenous thromboembolic eventsTotal shoulder arthroplastyHemophilia AImplant survivalMatched controlsThromboembolic eventsElixhauser Comorbidity IndexMale patientsAdverse eventsShoulder arthroplastyProsthesis survivalThromboembolic adverse eventsVenous thromboembolic event prophylaxisKaplan-Meier analysisFactor VIII levelsRevers total shoulder arthroplastyIndividual patient basisOdds of postoperative bleedingPostoperative bleedingBleeding complicationsTranexamic acidNinety-dayPatient basisControl cohortComorbidity index
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply